Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

16.48
-0.7400-4.30%
Post-market: 16.500.0200+0.12%19:31 EST
Volume:3.01M
Turnover:50.02M
Market Cap:1.68B
PE:-3.18
High:17.35
Open:16.94
Low:16.43
Close:17.22
52wk High:39.89
52wk Low:12.73
Shares:101.92M
Float Shares:77.74M
Volume Ratio:0.72
T/O Rate:3.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.1758
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-22.98%
PB:-4.47
PE(LYR):-2.83

Loading ...

Nov 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 10, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Nov 04, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2026

Major Issues Report

Form 8-K - Current report
Oct 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 20, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Oct 19, 2026

Major Issues Report

Form 8-K - Current report
Oct 14, 2026

Major Issues Report

Form 8-K - Current report
Oct 07, 2026

Major Issues Report

Form 8-K - Current report
Sep 17, 2026

Major Issues Report

Form 8-K - Current report
Sep 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2026

Major Issues Report

Form 8-K - Current report
Aug 19, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 11, 2026

Major Issues Report

Form 8-K - Current report
Aug 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2026

Major Issues Report

Form 8-K - Current report
Aug 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities